Retroperitoneal sarcomas (RPS) pose a challenge in treatment due to their rarity and complex nature. This retrospective study aimed to analyze the epidemiological, clinicopathological characteristics, and survival outcomes of RPS patients treated over an 11-year period. Seventeen patients diagnosed with RPS were included, with leiomyosarcoma being the most prevalent subtype. Surgical excision was the primary treatment modality, often complemented by radiotherapy and chemotherapy. The 5-year and 10-year overall survival rates were 56% and 46.9%, respectively, with a median progression-free survival of 10 months.
Discussion highlights the importance of complete surgical resection and tumor grade as prognostic indicators. Local recurrence remains a significant concern despite advancements in treatment modalities. The role of radiotherapy in reducing local recurrence risk is acknowledged, particularly in the preoperative setting. For metastatic RPS, a multidisciplinary approach integrating surgery and systemic therapy is crucial. Patient selection for surgical interventions considers tumor biology, disease burden, and response to chemotherapy. Chemotherapy, primarily anthracycline-based, remains a cornerstone in managing unresectable or metastatic disease, with emerging agents showing promise in clinical trials. Overall, a tailored treatment approach emphasizing radical resection and adjuvant therapies offers the best chance for long-term survival in RPS patients.
Cite this paper
Hajar, M. , Jihane, C. , Oumaima, S. , Chaymae, C. , Amira, S. , Lamiae, A. , Karima, O. , Zineb, B. , Samia, A. and Nawfel, M. (2024). Real-life Results of a Cohort of Retroperitoneal Sarcomas (RPS): Management at Hassan II University Hospital in Fes. Open Access Library Journal, 11, e1439. doi: http://dx.doi.org/10.4236/oalib.1111439.
Alvarenga, J.C., Ball, A.B., Fisher, C., Fryatt, I., Jones, L. and Thomas, J.M. (1991) Limitations of Surgery in the Treatment of Retroperitoneal Sarcoma. British Journal of Surgery, 78, 912-916. https://doi.org/10.1002/bjs.1800780806
Jacques, D.P., Coit, D.G., Hajdu, S.I. and Brennan, MF.. (1990) Management of Primary and Recurrent Soft Tissue Sarcoma of the Retroperitoneum. Annals of Surgery, 212, 51-59. https://doi.org/10.1097/00000658-199007000-00008
McGrath, P.C., Neifeld, J.P., Lawrence Jr., W., Demay, R.M., Kay, S., Horsley, J.S., et al. (1984) Improved Survival Following Complete Excision of Retroperitoneal Sarcomas. Annals of Surgery, 200, 200-204. https://doi.org/10.1097/00000658-198408000-00014
Singer, S., Corson, J.M., Demetri, G.D., Healey, E.A., Marcus, K. and Eberlein, T.J. (1995) Prognostic Factors Predictive of Survival for Truncal and Retroperitoneal Soft-Tissue Sarcoma. Annals of Surgery, 221, 185-195. https://doi.org/10.1097/00000658-199502000-00009
Singer, S., Antonescu, C.R., Riedel, E. and Brennan, M.F. (2003) Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitonealliposarcoma. Annals of Surgery, 238, 358-370. https://doi.org/10.1097/01.sla.0000086542.11899.38
Hassan, I., Park, S.Z., Donohue, J.H., Nagorney, D.M., Kay, P.A., Nasciemento, A.G., et al. (2004) Operative Management of Primary Retroperitoneal Sarcomas: A Reappraisal of an Institutional Experience. Annals of Surgery, 239, 244-250. https://doi.org/10.1097/01.sla.0000108670.31446.54
Heslin, M.J., Lewis, J.J., Nadler, E., Newman, E., Woodruff, J.M., Casper, E.S., et al. (1997) Prognostic Factors Associated with Long-Term Survival for Retroperitoneal Sarcoma: Implications for Management. Journal of Clinical Oncology, 15, 2832-2839. https://doi.org/10.1200/JCO.1997.15.8.2832
Stoeckle, E., Coindre, J.M., Bonvalot, S., Kantor, G., Terrier, P., Bonichon, F., et al. (2001) Prognostic Factors in Retroperitoneal Sarcoma: A Multivariate Analysis of A Series of 165patients of the French Cancer Center Federation Sarcoma Group. Cancer, 92, 359-368. https://doi.org/10.1002/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y
Avancès, C., Mottet, N., Mahatmat, A., Chapuis, E., Serre, I. and Culine, S.P. (2006) Rognosticfactors for First Recurrence in Patients with Retroperitoneal Sarcoma. Urologic Oncology, 24, 94-96. https://doi.org/10.1016/j.urolonc.2005.09.004
Bonvalot, S., Vanel, D., Le Cesne, A., Terrier, P. and Le Péchoux, C. (2006) Chirurgie Dessarcomes Rétropérionéaux. Cancer/Radiothérapie, 10, 41-49. https://doi.org/10.1016/j.canrad.2005.09.028
Catton, C.N., O’Sullivan, B., Kotwall, C., Cummings, B., Hao, Y. and Fornasier, V. (1994) Outcome and Prognosis in Retroperitoneal Soft Tissue Sarcoma. International Journal of Radiation Oncology, Biology, Physics, 29, 1005-1010. https://doi.org/10.1016/0360-3016(94)90395-6
Van Doorn, R.C., Gallee, M.P., Hart, A.A., Gortzak, E., Rutgers, E.J., Van Coevorden, F., et al. (1994) Resectable Retroperitoneal Soft Tissue Sarcomas. The Effect of Extentof Resection and Postoperative Radiation Therapy on Local Tumor Control. Cancer, 73, 637-642. https://doi.org/10.1002/1097-0142(19940201)73:3<637::AID-CNCR2820730322>3.0.CO;2-Y
Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG) (2018) Management of Metastatic Retroperitoneal Sarcoma: A Consensus Approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Annals of Oncology, 29, 857-871. https://doi.org/10.1093/annonc/mdy052
PalussièRe, J., Marcet, B., Descat, E., Deschamps, F., Rao, P., Ravaud, A., Brouste, V. and De Baère, T. (2011) Lung Tumors Treated with Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up. CardioVascular and Interventional Radiology, 34, 989-997. https://doi.org/10.1007/s00270-010-0048-z
Pawlik, T.M., Vauthey, J.N., Abdalla, E.K., Pollock, R.E., Ellis, L.M. and Curley, S.A. (2006) Results of a Single-Center Experience with Resection and Ablation for Sarcoma Metastatic to the Liver. Archives of Surgery, 141, 537-543. https://doi.org/10.1001/archsurg.141.6.537
Blackmon, S.H., Shah, N., Roth, J.A., Correa, A.M., Vaporciyan, A.A., Rice, D.C., Hofstetter, W., Walsh, G.L., Benjamin, R., Pollock, R., et al. (2009) Resection of Pulmonary and Extrapulmonary Sarcomatous Metastases Is Associated with Long-Term Survival. The Annals of Thoracic Surgery, 88, 877-885. https://doi.org/10.1016/j.athoracsur.2009.04.144
Stephens, E.H., Blackmon, S.H., Correa, A.M., Roth, J.A., Rice, D.C., Hofstetter, W., Benjamin, R., Mehran, R., Swisher, S.G., Walsh, G.L., et al. (2011) Progression after Chemotherapy Is a Novel Predictor of Poor Outcomes after Pulmonary Metastasectomy in Sarcoma Patients. Journal of the American College of Surgeons, 212, 821-826. https://doi.org/10.1016/j.jamcollsurg.2011.01.007
Maluccio, M.A., Covey, A.M., Schubert, J., Brody, L.A., Sofocleous, C.T., Getrajdman, G.I., DeMatteo, R. and Brown, K.T. (2006) Treatment of Metastatic Sarcoma to the Liver with Bland Embolization. Cancer, 107, 1617-1623. https://doi.org/10.1002/cncr.22191
Chapiro, J., Duran, R., Lin, M., Mungo, B., Schlachter, T., Schernthaner, R., Gorodetski, B., Wang, Z. and Geschwind, J.F. (2015) Transarterial Chemoembolization in Soft-Tissue Sarcoma Metastases to the Liver—The Use of Imaging Biomarkers as Predictors of Patient Survival. European Journal of Radiology, 84, 424-430. https://doi.org/10.1016/j.ejrad.2014.11.034
Weiser, M.R., Downey, R.J., Leung, D.H. and Brennan, M.F. (2000) Repeat Resection of Pulmonary Metastases in Patients with Soft-Tissue Sarcoma. Journal of the American College of Surgeons, 191, 184-190. https://doi.org/10.1016/S1072-7515(00)00306-9
Burt, B.M., Ocejo, S., Mery, C.M., Dasilva, M., Bueno, R., Sugarbaker, D.J. and Jaklitsch, M.T. (2011) Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends Survival. The Annals of Thoracic Surgery, 92, 1202-1207. https://doi.org/10.1016/j.athoracsur.2011.05.052
Cardona, K., Williams, R. and Movva, S. (2013) Multimodality Therapy for Advanced or Metastatic Sarcoma. Current Problems in Cancer, 37, 74-86. https://doi.org/10.1016/j.currproblcancer.2013.03.003
Wagner, M.J., Amodu, L.I., Duh, M.S., Korves, C., Solleza, F., Manson, S.C., Diaz, J., Neary, M.P. and Demetri, G.D. (2015) A Retrospective Chart Review of Drug Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Recurrent Soft Tissue Sarcoma Refractory to One or More Prior Chemotherapy Treatments. BMC Cancer, 15, Article No. 175. https://doi.org/10.1186/s12885-015-1182-4
Leahy, M., Garcia Del Muro, X., Reichardt, P., Judson, I., Staddon, A., Verweij, J., Baffoe-Bonnie, A., Jönsson, L., Musayev, A., Justo, N., et al. (2012) Chemotherapy Treatment Patterns and Clinical Outcomes in Patients with Metastatic Soft Tissue Sarcoma. The SArcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Annals of Oncology, 23, 2763-2770. https://doi.org/10.1093/annonc/mds070
Ryan, C.W., Merimsky, O., Agulnik, M., Blay, J.Y., Schuetze, S.M., Van Tine, B.A., Jones, R.L., Elias, A.D., Choy, E., Alcindor, T., et al. (2016) PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin with or without Palifosfamide in Patients with Metastatic Soft Tissue Sarcoma. Journal of Clinical Oncology, 34, 3898-3905. https://doi.org/10.1200/JCO.2016.67.6684
Judson, I., Radford, J.A., Harris, M., Blay, J.Y., Van Hoesel, Q., Le Cesne, A., Van Oosterom, A.T., Clemons, M.J., Kamby, C., Hermans, C., et al. (2001) Randomised Phase II Trial of Pegylated Liposomal Doxorubicin (DOXIL/CAELYX) versus Doxorubicin in the Treatment of Advanced or Metastatic Soft Tissue Sarcoma: A Study by the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer, 37, 870-877. https://doi.org/10.1016/S0959-8049(01)00050-8
Sleijfer, S., Ouali, M., Van Glabbeke, M., Krarup-Hansen, A., Rodenhuis, S., Le Cesne, A., Hogendoorn, P.C., Verweij, J. and Blay, J.Y. (2010) Prognostic and Predictive Factors for Outcome to First-Line Ifosfamide-Containing Chemotherapy for Adult Patients with Advanced Soft Tissue Sarcomas: An Exploratory, Retrospective Analysis on Large Series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). European Journal of Cancer, 46, 72-83. https://doi.org/10.1016/j.ejca.2009.09.022
Stacchiotti, S., Libertini, M., Negri, T., Palassini, E., Gronchi, A., Fatigoni, S., Poletti, P., Vincenzi, B., Dei Tos, A.P., Mariani, L., et al. (2013) Response to Chemotherapy of Solitary Fibrous Tumour: A Retrospective Study. European Journal of Cancer, 49, 2376-2383. https://doi.org/10.1016/j.ejca.2013.03.017
Le Cesne, A., Blay, J.Y., Judson, I., Van Oosterom, A., Verweij, J., Radford, J., Lorigan, P., Rodenhuis, S., Ray-Coquard, I., Bonvalot, S., et al. (2005) Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial. Journal of Clinical Oncology, 23, 576-584. https://doi.org/10.1200/JCO.2005.01.180
